Results 41 to 50 of about 1,631,567 (280)
Diagnostic formulation
Indian Journal of Psychiatry, 2010 Writing a 'Diagnostic Formulation' is a skill expected of candidates in the post-graduate examinations in psychiatry in most universities in India. However there is ambiguity regarding what the term means and how it should be written. This article is an attempt to provide some guidelines on this topic.Kuruvilla, K., Kuruvilla, Anjuopenaire +2 more sourcesClinical Insights Into Hypercalcemia of Malignancy in Childhood
Pediatric Blood &Cancer, EarlyView.ABSTRACT
Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.Hüseyin Anıl Korkmazwiley +1 more sourceFuel spray diagnostics [PDF]
, 1984 Several laser measurement methods are being studied to provide the capability to make droplet size and velocity measurements under a variety of spray conditions. The droplet sizing interferometer (DSI) promises to be a successful technique because of its Bosque, M. A.core +1 more sourceBioinformatics advances in saliva diagnostics [PDF]
, 2012 There is a need recognized by the National Institute of Dental & Craniofacial Research and the National Cancer Institute to advance
basic, translational and clinical saliva research. The goal of the Salivaomics Knowledge Base (SKB) is to create B Smith, Barry Smith, C Phillips, CM Huang, DA Natale, David TW Wong, DP Ng, E Birney, I Garcia, I Takeda, J Ai, Ji-Ye Ai, JM Guberman, K Degtyarenko, M Ashburner, P Grenon, RR Brinkman, S Hu +17 morecore +2 more sourcesValidation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy
Scientific Reports, 2022 Improved risk stratification of patients suspected of prostate cancer prior to biopsy continues to be an unmet clinical need. ExoDx Prostate (IntelliScore) “EPI” is a non-invasive urine test utilizing RNA from exosomes to provide a risk score that ...Alexander Kretschmer, Holger Kajau, Eric Margolis, Ronald Tutrone, Tobias Grimm, Matthias Trottmann, Christian Stief, Georg Stoll, Christian A. Fischer, Claudia Flinspach, Anja Albrecht, Lisa Meyer, Tina Priewasser, Daniel Enderle, Romy Müller, Phillipp Torkler, Jason Alter, Johan Skog, Mikkel Noerholm +18 moredoaj +1 more sourceSurvival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C
Pediatric Blood &Cancer, EarlyView.ABSTRACT Purpose
Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.Samuel Sassine, Ofélie Trudeau‐Ferrin, Caroline Laverdière, Patrick Hamel, Rosanne Superstein, Bénédicte Koukoui, Carole Provost, Paul C. Nathan, Vijay Ramaswamy, Furqan Shaikh, Brenda Gallie, Ashwin Mallipatna, Stephanie Kletke, Helen Dimaras, Hallie Coltin +14 morewiley +1 more sourceObservational Diagnostics of Gas Flows: Insights from Cosmological
Simulations
, 2017 Galactic accretion interacts in complex ways with gaseous halos, including
galactic winds. As a result, observational diagnostics typically probe a range
of intertwined physical phenomena. Because of this complexity, cosmological
hydrodynamic simulations A. B. Ford, A. Bauermeister, A. C. Fabian, A. Dekel, A. Dekel, A. Gould, A. L. Muratov, A. L. Muratov, A. M. Brooks, A. M. Diamond-Stanic, A. M. Wolfe, A. Rahmati, A. Rahmati, B. D. Oppenheimer, B. M. B. Henriques, B. Ménard, B. R. McNamara, C. B. Hummels, C. C. Steidel, C. C. Steidel, C. C. Steidel, C. C. Steidel, C. J. Liang, C. J. Liang, C. L. Martin, C. Martin, C.-A. Faucher-Giguère, C.-A. Faucher-Giguère, C.-A. Faucher-Giguère, C.-A. Faucher-Giguère, C.-A. Faucher-Giguère, C.-Y. Hu, D. B. Nestor, D. C. Martin, D. Ceverino, D. Ceverino, D. K. Erb, D. Kereš, D. Kereš, D. Nelson, D. Nelson, D. Nelson, D. R. Law, D. Sijacki, D. Zhang, E. Borisova, E. Wisnioski, F. Marinacci, F. S. Zahedy, F. Voort van de, F. Voort van de, F. Voort van de, F. Voort van de, F. Voort van de, G. Altay, G. C. Rudie, G. G. Kacprzak, G. G. Kacprzak, G. G. Kacprzak, G. G. Kacprzak, G. Kauffmann, G. S. Stinson, H.-W. Chen, J. A. Kollmeier, J. F. Hennawi, J. F. Hennawi, J. F. Navarro, J. I. Read, J. K. Werk, J. Ribaudo, J. Rosdahl, J. S. Mulchaey, J. Schaye, J. Schaye, J. Suresh, J. Tumlinson, J. X. Prochaska, J. X. Prochaska, J. X. Prochaska, J. X. Prochaska, J.-R. Gauthier, J.-T. Li, K. A. Kornei, K. Bundy, K. H. R. Rubin, K. H. R. Rubin, K. H. R. Rubin, K. L. Adelberger, K. R. Stewart, K. R. Stewart, K. Stewart, L. Corlies, L. Wisotzki, M. A. Fardal, M. Dijkstra, M. Dijkstra, M. E. Anderson, M. Fumagalli, M. Fumagalli, M. Fumagalli, M. L. Turner, M. L. Turner, M. L. Turner, M. Matuszewski, M. McQuinn, M. Neeleman, M. Rafelski, M. Rauch, M. Rauch, M. Rauch, M. Rauch, M. Rauch, M. S. Matejek, M. Vogelsberger, M. Vogelsberger, M. W. Lau, N. Bouché, N. Bouché, N. Bouché, N. H. M. Crighton, N. Lehner, N. Lehner, N. Lehner, N. M. Förster Schreiber, N. M. Förster Schreiber, N. Mandelker, N. Sravan, O. Agertz, O. Agertz, O. Agertz, P. Creasey, P. F. Hopkins, P. F. Hopkins, P. F. Hopkins, P. Torrey, R. A. Simcoe, R. Bacon, R. Bacon, R. Bordoloi, R. Bordoloi, R. Davé, R. F. Trainor, R. Genzel, R. M. Hutchings, R. S. Somerville, S. Bird, S. Cantalupo, S. Cantalupo, S. D. M. White, S. F. Newman, S. Frank, S. Shen, S. Shen, S. Shen, T. Goerdt, T. Goerdt, T. Goerdt, T. J. Cooper, T. Kimm, T. M. Heckman, T. R. Saitoh, V. Springel, Y. Birnboim, Y. Matsuda, Y. Taniguchi, Y. Taniguchi, Y. Yang, Z. Haiman +167 morecore +1 more sourcePersonalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study
Pediatric Blood &Cancer, EarlyView.ABSTRACT Objective
To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.Janka Kovács, Zoltán Köllő, Balázs Gellért Karvaly, Mahmoud Obeidat, Rita Nagy, Péter Hegyi, Brigitta Teutsch, Eszter Tuboly, Miklós Garami +8 morewiley +1 more sourceEvolutionary Events in a Mathematical Sciences Research Collaboration
Network [PDF]
, 2015 This study examines long-term trends and shifting behavior in the
collaboration network of mathematics literature, using a subset of data from
Mathematical Reviews spanning 1985-2009.A. Barrat, A. Clauset, A. Fronczak, A. L. Barabási, Antonio McInnes, Brianna Richardson, Christopher Franck, F. Chung, F. Morillo, J. A. Davis, J. L. Guillaume, J. Spencer, Jason Cory Brunson, M. E. J. Newman, M. E. J. Newman, M. Molloy, M. Perc, Monisha Narayan, P. Erdős, P. Grindrod, P. Holme, Patrick Ion, Reinhard Laubenbacher, S. Maslov, S. N. Soffer, Steve Fassino, T. Opsahl, V. D. Blondel, V. Latora, W. Glänzel +29 morecore +1 more source